NEU 4.59% $17.30 neuren pharmaceuticals limited

Acadia, page-298

  1. 2,057 Posts.
    lightbulb Created with Sketch. 490
    It's kind of funny how it works. When this (or any company) doesn't live up to Broker expectations, even when the company has given credible and realistic guidance that the analysts have chosen to go beyond, they subsequently adjust their view and the share price of the company takes the hit. It's kind of a weirdly negative confirmation bias. It leads to the incentivizing, for companies, of underestimating real targets to avoid 'missing them'. Fact is: Acadia, with a soaring new product in Daybue, that could have done anything, absolutely nailed their guidance. The Brokers not so much. Who should be called to account?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$17.30
Change
0.760(4.59%)
Mkt cap ! $2.211B
Open High Low Value Volume
$17.35 $17.94 $17.25 $17.64M 1.010M

Buyers (Bids)

No. Vol. Price($)
3 2533 $17.30
 

Sellers (Offers)

Price($) Vol. No.
$17.45 1254 1
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.